Literature DB >> 20802227

Dual role of the carboxyl-terminal region of pig liver L-kynurenine 3-monooxygenase: mitochondrial-targeting signal and enzymatic activity.

Kumiko Hirai1, Hidehito Kuroyanagi, Yoshitaka Tatebayashi, Yoshitaka Hayashi, Kanako Hirabayashi-Takahashi, Kuniaki Saito, Seiich Haga, Tomihiko Uemura, Susumu Izumi.   

Abstract

l-kynurenine 3-monooxygenase (KMO) is an NAD(P)H-dependent flavin monooxygenase that catalyses the hydroxylation of l-kynurenine to 3-hydroxykynurenine, and is localized as an oligomer in the mitochondrial outer membrane. In the human brain, KMO may play an important role in the formation of two neurotoxins, 3-hydroxykynurenine and quinolinic acid, both of which provoke severe neurodegenerative diseases. In mosquitos, it plays a role in the formation both of eye pigment and of an exflagellation-inducing factor (xanthurenic acid). Here, we present evidence that the C-terminal region of pig liver KMO plays a dual role. First, it is required for the enzymatic activity. Second, it functions as a mitochondrial targeting signal as seen in monoamine oxidase B (MAO B) or outer membrane cytochrome b(5). The first role was shown by the comparison of the enzymatic activity of two mutants (C-terminally FLAG-tagged KMO and carboxyl-terminal truncation form, KMOΔC50) with that of the wild-type enzyme expressed in COS-7 cells. The second role was demonstrated with fluorescence microscopy by the comparison of the intracellular localization of the wild-type, three carboxyl-terminal truncated forms (ΔC20, ΔC30 and ΔC50), C-terminally FLAG-tagged wild-type and a mutant KMO, where two arginine residues, Arg461-Arg462, were replaced with Ser residues.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20802227     DOI: 10.1093/jb/mvq099

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  9 in total

Review 1.  Advantages of brain penetrating inhibitors of kynurenine-3-monooxygenase for treatment of neurodegenerative diseases.

Authors:  Shaowei Zhang; Mary E W Collier; Derren J Heyes; Flaviano Giorgini; Nigel S Scrutton
Journal:  Arch Biochem Biophys       Date:  2020-12-01       Impact factor: 4.013

2.  Bacterial expression of human kynurenine 3-monooxygenase: solubility, activity, purification.

Authors:  K Wilson; D J Mole; M Binnie; N Z M Homer; X Zheng; B A Yard; J P Iredale; M Auer; S P Webster
Journal:  Protein Expr Purif       Date:  2013-12-04       Impact factor: 1.650

3.  Full-length in meso structure and mechanism of rat kynurenine 3-monooxygenase inhibition.

Authors:  Shinya Mimasu; Hiroaki Yamagishi; Satoshi Kubo; Mie Kiyohara; Toshihiro Matsuda; Toshiko Yahata; Heather A Thomson; Christopher D Hupp; Julie Liu; Takao Okuda; Kenichi Kakefuda
Journal:  Commun Biol       Date:  2021-02-04

Review 4.  The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors.

Authors:  Tamera D Hughes; Osman F Güner; Emma Carine Iradukunda; Robert S Phillips; J Phillip Bowen
Journal:  Molecules       Date:  2022-01-02       Impact factor: 4.411

5.  Cellular Localization of Kynurenine 3-Monooxygenase in the Brain: Challenging the Dogma.

Authors:  Korrapati V Sathyasaikumar; Verónica Pérez de la Cruz; Benjamín Pineda; Gustavo Ignacio Vázquez Cervantes; Daniela Ramírez Ortega; David W Donley; Paul L Severson; Brian L West; Flaviano Giorgini; Jonathan H Fox; Robert Schwarcz
Journal:  Antioxidants (Basel)       Date:  2022-02-04

Review 6.  Kynurenic Acid Acts as a Signaling Molecule Regulating Energy Expenditure and Is Closely Associated With Metabolic Diseases.

Authors:  Delong Zhen; Junjun Liu; Xu Dong Zhang; Zehua Song
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-24       Impact factor: 5.555

7.  Pharmacophore-Based Virtual Screening of Novel Competitive Inhibitors of the Neurodegenerative Disease Target Kynurenine-3-Monooxygenase.

Authors:  Lizaveta Gotina; Seon Hee Seo; Chae Won Kim; Sang Min Lim; Ae Nim Pae
Journal:  Molecules       Date:  2021-05-31       Impact factor: 4.411

Review 8.  Kynurenine-3-monooxygenase: A new direction for the treatment in different diseases.

Authors:  Yifei Lu; Mingmei Shao; Tao Wu
Journal:  Food Sci Nutr       Date:  2020-01-20       Impact factor: 2.863

9.  A novel role for kynurenine 3-monooxygenase in mitochondrial dynamics.

Authors:  Daniel C Maddison; Mónica Alfonso-Núñez; Aisha M Swaih; Carlo Breda; Susanna Campesan; Natalie Allcock; Anna Straatman-Iwanowska; Charalambos P Kyriacou; Flaviano Giorgini
Journal:  PLoS Genet       Date:  2020-11-10       Impact factor: 5.917

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.